Exclusive: Pharmaceutical research firm PPD explores sale, IPO – Reuters


Reuters
Exclusive: Pharmaceutical research firm PPD explores sale, IPO
Reuters
Contract research organization Pharmaceutical Product Development LLC (PPD) is exploring a sale or initial public offering that could value it at between $7 billion and $8 billion, including debt, people familiar with the matter said. A deal would
Exclusive – Pharmaceutical research firm PPD explores sale, IPO: sourcesInteractive Investor

all 12 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd